4 completed, 2 not yet recruiting, 2 recruiting. 5 Phase 2, 3 Phase 1, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 3 | Completed 3 |
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Prostate Cancer Patients Undergoing Radical Prostatectomy: new trials by email Literature Review of Prostate Cancer Patients Undergoing Radical Prostatectomy trials Research Report on Prostate Cancer Patients Undergoing Radical Prostatectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows 12 h before RP, 24 h before RP, 36 h before RP - Prostate Cancer Patients Undergoing Radical Prostatectomy | Phase 2 | Not yet recruiting | Haitao Niu, MD | 27 | 2026-02-27 | 2026-02-04 |
| Ejaculatory Behavior and Seminal Vesicle Size During Radical Prostatectomy Recent Ejaculation, Preoperative Abstinence - Prostate Cancer Patients Undergoing Radical Prostatectomy | Not applicable | Not yet recruiting | National Taiwan University Hospital | 40 | 2025-12-01 | 2025-12-03 |
| Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate Cancer Radical prostatectomy with extended / limited lymph node dissection, Radical prostatectomy with limited / no lymph node dissection - Prostate Cancer Patients Undergoing Radical Prostatectomy | Not applicable | Recruiting | N.N. Alexandrov National Cancer Centre | 800 | 2025-10-29 | 2025-12-30 |
| Safety and Efficacy Trial of a Targeted PSMA Fluorescent Contrast Agent (DGPR1008) for Intraoperative Imaging of Prostate Cancer 0.02mg/kg, 0.04mg/kg - Prostate Cancer Patients Undergoing Radical Prostatectomy | Phase 2 | Completed | Haitao Niu, MD | 24 | 2024-10-30 | 2025-06-17 |
| FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer FK-PC101, Standard of Care (SOC) - Prostate Cancer (Adenocarcinoma), Prostate CA | Phase 2 | Recruiting | Cellvax Therapeutics Inc | 100 | 2024-10-14 | 2024-10-21 |
| Research on PSMA-Targeted Intraoperative Fluorescent Imaging Agents 0.01mg/kg DGPR1008 Injection Dose Group 1 (n=6), 0.02mg/kg DGPR1008 Injection Dose Group 2 (n=6), 0.04mg/kg DGPR1008 Injection Dose Group 3 (n=6) - Prostate Cancer Patients Undergoing Radical Prostatectomy, Prostate CA | Phase 1 | Completed | Haitao Niu, MD | 32 | 2024-06-24 | 2025-08-03 |
| Advanced Pelvic Floor Training Program for Prostate Cancer Surgery Advanced Pelvic Floor Muscle Exercise (APFX) - Prostate Cancer Patients Undergoing Radical Prostatectomy | Phase 1 / Phase 2 | Completed | University of Guelph-Humber | 88 | 2015-01-01 | 2017-10-26 |
| Prehabilitation for Prostate Cancer Surgery Prehabilitation (PREHAB) - Prostate Cancer Patients Undergoing Radical Prostatectomy | Phase 1 / Phase 2 | Completed | University of Guelph-Humber | 86 | 2013-11-01 | 2017-08-23 |
Prostatic Neoplasms (5) · Adenocarcinoma (1) · Urinary Incontinence (1)
Genital Diseases (5) · Genital Diseases, Male (5) · Genital Neoplasms, Male (5) · Male Urogenital Diseases (5) · Neoplasms (5) · Neoplasms by Site (5) · Prostatic Diseases (5) · Urogenital Diseases (5) · Urogenital Neoplasms (5) · Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Lower Urinary Tract Symptoms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
Infusions, Intravenous (1) · Preoperative Exercise (1) · Standard of Care (1)
Haitao Niu, MD (3) · University of Guelph-Humber (2) · Cellvax Therapeutics Inc (1) · N.N. Alexandrov National Cancer Centre (1) · National Taiwan University Hospital (1)
China (3) · Canada (2) · Belarus (1) · Taiwan (1) · United States (1)